Replacement Director/PDMR Shareholding

RNS Number : 7899B

Plant Health Care PLC

24 February 2011

 



Plant Health Care plc

Thursday, 24 February 2011

This announcement replaces 7241B released on 23 February 2011 at 13.30

The change is to correct a mistyped figure in the penultimate paragraph where 53,031,789 has been changed to the correct figure of 53,031,798

PLANT HEALTH CARE plc (THE "COMPANY")

Additional Listing and Directors' Shareholdings - REPLACEMENT

On 22 February, the Company approved the allotment of 71,516 ordinary shares of 1p ("Ordinary Shares") to the following non-executive directors, in accordance with the Company's existing contractual arrangements, which comprise part of the non-executive directors' remuneration packages and are payable in lieu of a part of their fees.  The shares were allotted at 61p per share, calculated at the closing middle market price derived from the Daily Official List on 21 February 2011. 

Non-executive director	Value of remuneration used to purchase shares	Number of Ordinary Shares allotted
Dominik Koechlin	£12,875.00	21,107
Sam Wauchope	£10,250.00	16,803
David Buckeridge	£10,250.00	16,803
Jeremy Scudamore	£10,250.00	16,803
	TOTAL:	71,516

Following the above-mentioned allotments, the beneficial interests of the non-executive directors in the enlarged Ordinary Share capital of the Company are as shown below:

Name	Ordinary Share holding	Percentage of enlarged Ordinary Share capital	Share Options
Dominik Koechlin	178,591	0.34%	N/A
Sam Wauchope	106,229	0.20%	N/A
David Buckeridge	105,355	0.20%	N/A
Jeremy Scudamore	102,854	0.19%	N/A

Application has been made for 71,516 Ordinary Shares (the 'New Shares') to be admitted to trading on AIM and admission is expected to occur on 28 February 2011.  The New Shares will rank pari passu with the Company's existing Ordinary Shares. 

Following admission of the New Shares, the total issued share capital of the Company will be 53,031,798 Ordinary Shares, all of which have voting rights. 

The above figure (53,031,798) may be used by shareholders as the denominator for the calculations by which they will determine if they are required to notify their interest in, or a change to their interest in, Plant Health Care plc under the FSA's Disclosure and Transparency Rules. 

-: Ends :-

Enquiries:

Andrew C. Wood FCIS

Company Secretary                                              

020 8866 5702

Evolution Securities Limited                                      Tavistock Communications

Tim Worlledge/Tim Redfern                                            Jeremy Carey/Matt Ridsdale

Tel: [phone]                                                          Tel: [phone]

 

END

 

 

RDSKZLBLFLFEBBQ